INVESTOR ALERT: Investigation of AVITA Medical, Inc. (RCEL) Announced by Holzer & Holzer, LLC

ATLANTA, Aug. 22, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether AVITA Medical, Inc. (“AVITA” or the “Company”) (NASDAQ: RCEL) complied with federal securities laws. On August 7, 2025, AVITA reported second quarter 2025 results and revised its 2025 guidance, stating that the Company experienced a “significant headwind from a temporary gap in Medicare Administrative Contractor (MAC) payments to providers for the use of our flagship RECELL® System, which led to a weakening in demand. Multiple MACs initiated payments in July with resolution expected in Q3.” Following this report, the price of the Company’s stock dropped. 

If you purchased AVITA stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at [email protected] or Joshua Karr, Esq. at [email protected], call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/avita-medical/ to discuss your legal rights.  

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.  
  
CONTACT:  
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
[email protected]

Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow